Form D · Biotechnology

UROMEDICA INC

Plymouth, MN · CIK 0001053415

Offering snapshot reported Jan 17, 2019 · SEC filing

Reported sold
$600K
Offering amount: $4M
Investors reported
12
Form D · investor count
Minimum accepted
$50K
Reported outside-investor minimum
First sale
Dec 31, 2018
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 17, 2019Initial$600,000No comparison12SEC filing
Apr 15, 2013InitialYet to sellNo comparison0SEC filing
Dec 28, 2011Initial$1,250,000No comparison7SEC filing
Oct 25, 2007PaperNot reportedNo comparisonNot reportedSEC filing
May 4, 2007PaperNot reportedNo comparisonNot reportedSEC filing
Dec 13, 2006PaperNot reportedNo comparisonNot reportedSEC filing
Mar 8, 2005PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06c
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-330785

Source: Form D, filed Jan 17, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
David Booth Director
John H Burton Director, Executive
Stephen Clark Director
Timothy C Cook Director, Executive
Douglas Gladder Director
Douglas Glader Director
John Haveman Director
Theodore Herzog Director
John L Reineck Executive
Kerry Vermeer Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1840 Berkshire Lane North
Plymouth, MN, 55441